AP-III-a4
ENOblock is a potent, first-in-class nonsubstrate analogue inhibitor of enolase, exhibiting an IC50 of 0.576 μM. It is widely used in biochemical and cancer metabolism research, with applications in both in vitro enzymatic assays and in vivo studies exploring tumor growth inhibition.
Product Specifications
CAS Number
1177827-73-4
Product Name Alternative
Apoptosis, AP III a4, APIIIa4, AP-III-a4, AP-III-a-4, anticancer, antidiabetic, inhibit, Inhibitor, Huh7, enolase, Enolase, ENOblock, HEK, HCT116, zebrafish, Phosphopyruvate hydratase
Field of Research
Cell Biology, Metabolism Research
Purity
98.24% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.41 mM) ; DMSO:257.5 mg/mL (432.98 mM)
Smiles
NCCOCCOCCNC (=O) Cc1ccc (Nc2nc (NCC3CCCCC3) nc (NCc3ccc (F) cc3) n2) cc1
Molecular Formula
C31H43FN8O3
Molecular Weight
594.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
219137-01 20 µL
PIGR (Polymeric Immunoglobulin Receptor) discontinued
Sign In for Pricing
View Details 
219137-02 100 µL
PIGR (Polymeric Immunoglobulin Receptor) discontinued
Sign In for Pricing
View Details 
